187 related articles for article (PubMed ID: 23471305)
21. Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
Buchmann I; Bunjes D; Kotzerke J; Martin H; Glatting G; Seitz U; Rattat D; Buck A; Döhner H; Reske SN
Cancer Biother Radiopharm; 2002 Apr; 17(2):151-63. PubMed ID: 12030109
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation.
Bethge WA; Wilbur DS; Sandmaier BM
Leuk Lymphoma; 2006 Jul; 47(7):1205-14. PubMed ID: 16923548
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
Behr TM; Sgouros G; Vougiokas V; Memtsoudis S; Gratz S; Schmidberger H; Blumenthal RD; Goldenberg DM; Becker W
Int J Cancer; 1998 May; 76(5):738-48. PubMed ID: 9610734
[TBL] [Abstract][Full Text] [Related]
24. Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia.
Glatting G; Müller M; Koop B; Hohl K; Friesen C; Neumaier B; Berrie E; Bird P; Hale G; Blumstein NM; Waldmann H; Bunjes D; Reske SN
J Nucl Med; 2006 Aug; 47(8):1335-41. PubMed ID: 16883014
[TBL] [Abstract][Full Text] [Related]
25. Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates.
Green DJ; Pagel JM; Nemecek ER; Lin Y; Kenoyer A; Pantelias A; Hamlin DK; Wilbur DS; Fisher DR; Rajendran JG; Gopal AK; Park SI; Press OW
Blood; 2009 Aug; 114(6):1226-35. PubMed ID: 19515724
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
[TBL] [Abstract][Full Text] [Related]
27. Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with
Bäck T; Chouin N; Lindegren S; Kahu H; Jensen H; Albertsson P; Palm S
J Nucl Med; 2017 Apr; 58(4):598-604. PubMed ID: 27688477
[TBL] [Abstract][Full Text] [Related]
28. Radioimmunotherapy for Treatment of Acute Leukemia.
Bodet-Milin C; Kraeber-Bodéré F; Eugène T; Guérard F; Gaschet J; Bailly C; Mougin M; Bourgeois M; Faivre-Chauvet A; Chérel M; Chevallier P
Semin Nucl Med; 2016 Mar; 46(2):135-46. PubMed ID: 26897718
[TBL] [Abstract][Full Text] [Related]
29. Possibility of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using
Oriuchi N; Aoki M; Ukon N; Washiyama K; Tan C; Shimoyama S; Nishijima KI; Takahashi K; Ito H; Ikezoe T; Zhao S
Sci Rep; 2020 Apr; 10(1):6810. PubMed ID: 32321944
[TBL] [Abstract][Full Text] [Related]
30. Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man.
Brenner MK; Wulf GG; Rill DR; Luo KL; Goodell MA; Mei Z; Kuehnle I; Brown MP; Pule M; Heslop HE; Krance RA
Ann N Y Acad Sci; 2003 May; 996():80-8. PubMed ID: 12799286
[TBL] [Abstract][Full Text] [Related]
31. Preclinical studies targeting normal and leukemic hematopoietic cells with Yttrium-90-labeled anti-CD45 antibody in vitro and in vivo in nude mice.
Vallera DA; Elson M; Brechbiel MW; Dusenbery KE; Burns LJ; Skubitz KM; Jaszcz WB; Ramsay NK; Panoskaltsis-Mortari A; Kuroki DW; Wagner JE; Kersey JH
Cancer Biother Radiopharm; 2003 Apr; 18(2):133-45. PubMed ID: 12804039
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
Kelly MP; Lee ST; Lee FT; Smyth FE; Davis ID; Brechbiel MW; Scott AM
Prostate; 2009 Jan; 69(1):92-104. PubMed ID: 18942092
[TBL] [Abstract][Full Text] [Related]
33. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
34. Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.
Pagel JM; Hedin N; Subbiah K; Meyer D; Mallet R; Axworthy D; Theodore LJ; Wilbur DS; Matthews DC; Press OW
Blood; 2003 Mar; 101(6):2340-8. PubMed ID: 12446461
[TBL] [Abstract][Full Text] [Related]
35. Radioimmunoconjugates in acute leukemia treatment: the future is radiant.
Kotzerke J; Bunjes D; Scheinberg DA
Bone Marrow Transplant; 2005 Dec; 36(12):1021-6. PubMed ID: 16247432
[TBL] [Abstract][Full Text] [Related]
36. Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.
Park SI; Shenoi J; Pagel JM; Hamlin DK; Wilbur DS; Orgun N; Kenoyer AL; Frayo S; Axtman A; Bäck T; Lin Y; Fisher DR; Gopal AK; Green DJ; Press OW
Blood; 2010 Nov; 116(20):4231-9. PubMed ID: 20702781
[TBL] [Abstract][Full Text] [Related]
37. Improved experimental cancer therapy by radioantibody dose intensification as a result of syngeneic bone marrow transplantation.
Blumenthal RD; Sharkey RM; Forman D; Wong G; Hess J; Goldenberg DM
Exp Hematol; 1995 Sep; 23(10):1088-97. PubMed ID: 7656929
[TBL] [Abstract][Full Text] [Related]
38. Paradoxical effects of Auger electron-emitting (111)In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45(+) cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice.
Bergstrom D; Leyton JV; Zereshkian A; Chan C; Cai Z; Reilly RM
Nucl Med Biol; 2016 Oct; 43(10):635-41. PubMed ID: 27497632
[TBL] [Abstract][Full Text] [Related]
39. Antibody-targeted therapy for myeloid leukemia.
Appelbaum FR
Semin Hematol; 1999 Oct; 36(4 Suppl 6):2-8. PubMed ID: 10530710
[TBL] [Abstract][Full Text] [Related]
40. Modelling radioimmunotherapy with anti-CD45 antibody to obtain a more favourable biodistribution.
Kiraly F; Kletting P; Reske S; Glatting G
Nuklearmedizin; 2009; 48(3):113-9. PubMed ID: 19322499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
